Pay in 4 interest-free payments of $5.29 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
What is my copay or coinsurance
GLP-1 receptor agonists are not recommended for use in patients with severe gastrointestinal disease, including gastroparesis
Milligrams measure the actual amount of active medication
The 48-week timeframe for retatrutide is shorter than the semaglutide and tirzepatide trials, which makes the comparison even more striking
Combining the two, especially in people with a history of pancreatitis or heavy drinking, creates a cumulative risk that exceeds either factor alone
US$ 26.31
US$ 27.20
US$ 24.55
US$ 21.47
US$ 25.73
US$ 27.61
US$ 26.20
